These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 12800985

  • 1. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
    Rosei EA, Rizzoni D, Comini S, Boari G, Nebivolol-Lisinopril Study Group.
    Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
    [Abstract] [Full Text] [Related]

  • 2. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators.
    Lancet; 2014 May 31; 383(9932):1889-98. PubMed ID: 24881993
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).
    Czuriga I, Riecansky I, Bodnar J, Fulop T, Kruzsicz V, Kristof E, Edes I, NEBIS Investigators, NEBIS Investigators Group.
    Cardiovasc Drugs Ther; 2003 May 31; 17(3):257-63. PubMed ID: 14574084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA, Basile J, Stapff M, Khan B, Zhou D.
    J Clin Hypertens (Greenwich); 2012 Sep 31; 14(9):588-92. PubMed ID: 22947356
    [Abstract] [Full Text] [Related]

  • 8. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.
    Am J Ther; 1999 May 31; 6(3):137-47. PubMed ID: 10423656
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 31; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov 31; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 11. Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial.
    Van Nueten L, Schelling A, Vertommen C, Dupont AG, Robertson JI.
    J Hum Hypertens; 1997 Dec 31; 11(12):813-9. PubMed ID: 9468009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun 31; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 31; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 15. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
    Redón J, Pascual-Izuel JM, Rodilla E, Vicente A, Oliván J, Bonet J, Torguet JP, Calaforra O, Almirall J.
    Blood Press; 2014 Jun 31; 23(3):181-8. PubMed ID: 24059690
    [Abstract] [Full Text] [Related]

  • 16. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.
    Malacco E, Santonastaso M, Varì NA, Gargiulo A, Spagnuolo V, Bertocchi F, Palatini P, Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril Study.
    Clin Ther; 2004 Jun 31; 26(6):855-65. PubMed ID: 15262456
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A, Punzi H, Luo X, Stapff M.
    Clin Ther; 2013 Feb 31; 35(2):142-52. PubMed ID: 23332366
    [Abstract] [Full Text] [Related]

  • 18. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
    Fogari R, Zoppi A, Carretta R, Veglio F, Salvetti A, Italian Collaborative Study Group.
    J Hypertens; 2002 May 31; 20(5):1007-14. PubMed ID: 12011663
    [Abstract] [Full Text] [Related]

  • 19. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 20. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G, Johnson ML.
    Clin Exp Hypertens; 1993 May 27; 15(3):501-9. PubMed ID: 8098243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.